Home > Products > Pharmaceuticals & Life Science > Biotechnology & Diagnostics > Methyl cis-1-Boc-4-hydroxy-D-prolinate
Methyl cis-1-Boc-4-hydroxy-D-prolinate structure, CAS 114676-69-6

Methyl cis-1-Boc-4-hydroxy-D-prolinate

CAS Number114676-69-6

Synonyms1-O-tert-butyl 2-O-methyl (2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate; Methyl Cis-1-Boc-4-Hydroxy-D-Prolinate; N-Boc-cis-4-hydroxy-D-proline methyl ester

Molecular FormulaC11H19O5N1

Molecular Weight245.28

Purity98.00%

Density1.216g/cm3

Boiling Point335.2ºC at 760mmHg

Melting Point80 °C

Flash Point

AppearancePowder | White

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9050842 Purity: 98.00%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 114676-69-6 ] Purity: 98.00% SDS Specification MoL

Chemical & Physical Properties
CAS Number114676-69-6
Catalog No.2A-9050842
Chinese Name顺式-1-N-叔丁氧羰基-4-羟基-D-脯氨酸甲酯
Synonyms1-O-tert-butyl 2-O-methyl (2R,4R)-4-hydroxypyrrolidine-1,2-dicarboxylate; Methyl Cis-1-Boc-4-Hydroxy-D-Prolinate; N-Boc-cis-4-hydroxy-D-proline methyl ester
Molecular FormulaC11H19O5N1
Molecular Weight245.28
Purity98.00
Density1.216g/cm3
Boiling Point335.2ºC at 760mmHg
Melting Point80 °C
AppearancePowder | White
Storage Conditionroom temperature
ApplicationN-Boc-cis-4-hydroxy-D-proline methyl ester is a non-cleavable ADC linker for the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-D-proline methyl ester is also an alkyl chain-based P
HTC2933990090
MDL NumberMFCD00797548
MSDSmsds/50842_1_114676_69_6.pdf
BioactivityN-Boc-cis-4-hydroxy-D-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-D-proline methyl ester is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1 Related Catalog Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker Signaling Pathways >> PROTAC >> PROTAC Linker Target Non-cleavable In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. References [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. Chemical & Physical Properties Density 1.216g/cm3 Boiling Point 335.2ºC at 760mmHg Melting Point 80 °C Molecular Formula C11H19NO5 Molecular Weight 245.27200 Flash Point 156.6ºC Exact Mass 245.12600 PSA 76.07000 LogP 0.46760 Appearance of Characters Powder | White Vapour Pressure 8.47E-06mmHg at 25°C Index of Refraction 1.5
Use ofN-Boc-cis-4-hydroxy-D-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-D-proline methyl ester is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1 Properties Name Methyl (2R,4R)-1-Boc-4-hydroxypyrrolidine-2-carboxylate Synonym More Synonyms Biological Activity Description N-Boc-cis-4-hydroxy-D-proline methyl ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). N-Boc-cis-4-hydroxy-D-proline methyl ester is also a alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1 Related Catalog Research Areas >> Cancer Signaling Pathways >> Antibody-drug Conjugate >> ADC Linker Signaling Pathways >> PROTAC >> PROTAC Linker Non-cleavable In Vitro ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1]. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. References [1]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315-337. [2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985. Chemical & Physical Properties Molecular Formula C11H19NO5 Exact Mass 245.12600 PSA 76.07000 LogP 0.46760 Appearance of Characters Powder | White Index of Refraction 1.5
Tax Rebate13.0%
SupervisionNone. MFN tariff: 6.5%. Ordinary tariff: 20.0%
Transport InfoProduct name: Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA